IHC - Factor XIII a Test, Price, Normal Range | Sprint Diagnostics Hyderabad

No, fasting is not required for this test. The test is performed on a tissue sample, typically obtained via biopsy, not on a blood sample.

There is no specific preparation needed for this test. However, it is always important to inform your doctor about any medications, supplements, or health conditions that might interfere with test results.

This test is typically ordered when a skin lesion or tumor has characteristics that make it difficult to diagnose based on physical examination and routine histopathology alone.

Ultrasound imaging can reveal liver size, shape, and detect any abnormalities or structural issues.

This test provides information about the presence or absence of Factor XIII a in the tissue sample. This can help in diagnosing certain skin conditions and in differentiating between benign and malignant skin tumors.

The frequency of this test depends on individual circumstances and is determined by your doctor. It is not typically a test that is performed regularly, but rather as needed to aid in diagnosis.

In normal tissues, Factor XIII a is typically present in certain cells, including platelets and other cell types. In the context of skin tumors, the presence or absence of Factor XIII a can help differentiate between different types of tumors. However, the results of this test must always be interpreted in the context of the patient's clinical picture and other diagnostic tests.

After the tissue sample is taken, you might experience slight discomfort, bleeding, or bruising at the biopsy site. Follow your doctor's post-procedure instructions carefully to care for the biopsy site and monitor for signs of infection, such as increased pain, redness, swelling, or pus.

The level of Factor XIII a can be affected by various factors, including certain medications and health conditions. For example, in certain types of skin tumors, Factor XIII a is typically absent or reduced.

If your Factor XIII a levels are abnormal, you should consult a dermatologist or a pathologist. They can interpret the test results in the context of your overall clinical picture and guide you regarding further steps.

Yes, the Factor XIII a IHC test can help distinguish between different types of skin lesions. For example, dermatofibromas typically stain positive for Factor XIII a, while dermatofibrosarcoma protuberans usually do not. However, the test results should always be interpreted alongside other clinical findings and diagnostic tests.

Low or absent levels of Factor XIII a in a skin lesion can indicate certain types of tumors such as dermatofibrosarcoma protuberans. However, interpretation of test results should be done by your doctor, considering your overall clinical picture and other diagnostic tests.

The primary risk associated with this test is related to the biopsy procedure, which is how the tissue sample for testing is obtained. Risks of biopsy include pain, bleeding, infection, and bruising at the site of the biopsy.

Factor XIII a levels are determined primarily by the characteristics of the tissue being examined, not by lifestyle factors. However, certain medications could potentially influence Factor XIII a expression. Always inform your doctor about any medications, supplements, or health conditions you have before undergoing this test.

This test is typically available in laboratories that offer specialized immunohistochemical testing. Your healthcare provider can provide more information about where to get this test.

The IHC - Factor XIII a diagnostic test offers a precise and useful method for aiding in the diagnosis of certain skin conditions. By highlighting the presence or absence of Factor XIII a, it can help clinicians differentiate between various skin lesions and decide on the most appropriate course of treatment. It's important to discuss any concerns or questions you might have with your healthcare provider, who can interpret the test results in the context of your overall health and medical history.